Barcelona, Spain, and Cambridge, United States – April 28th – Pharmacelera, the leading provider of advanced computational tools for drug discovery, and
Barcelona, Spain, and Kyiv, Ukraine – March 3, 2026 – Pharmacelera, the deeptech company pushing the limits of computational technologies for drug
Boston and Barcelona — February 23, 2026 — Pharmacelera, a deep-tech company developing and applying high-accuracy Quantum Mechanics and Artificial Intelligence (“deep
Round led by Heran Partners and joined by Clave Capital, Inveready and Bio&Tech Smart Capital Financing will enable Pharmacelera to build ongoing
California, US & Barcelona, Spain — October 13th, 2025 — Together with eMolecules we announce the launch of a new integrated solution combining ExaScreen® with
Cambridge, UK & Barcelona, Spain — August 27th, 2025 — Domainex, a leading integrated drug discovery services company, and Pharmacelera, a pioneer
We are thrilled to announce a collaboration between Pharmacelera and the UMass Chan Medical School aimed to support early-stage drug discovery projects.
Barcelona, Leiden and Uppsala, July 2nd 2024 – Pharmacelera, the leading provider of computational tools for hit discovery, the Leiden Academic Center
